5-Hydroxytryptamine2B receptor function is enhanced in the Nω-nitro-L-arginine hypertensive rat

Journal of Pharmacology and Experimental Therapeutics

Volumn 303, Issue 1, 2002, Pages 179-187

  Russell, Amber ^a   Banes, Amy ^a   Berlin, Hilary ^a   Fink, Gregory D ^a   Watts, Stephanie W ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [5 (2 THIENYLMETHOXY) 1H 3 INDOLYL]PROPAN 2 AMINE; 6 METHYL 1,2,3,4 TETRAHYDRO 1 [(3,4 DIMETHOXYPHENYL)METHYL] 9H PYRIDO[3,4 B]INDOLE; KETANSERIN; LY 272015; N(G) NITROARGININE; PHENYLEPHRINE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; HYPERTENSION; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR UPREGULATION; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AORTA, THORACIC; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; KETANSERIN; MALE; NITROARGININE; ORGANIC CHEMICALS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2B; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; VASOCONSTRICTION;

EID: 0036786399     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.037390     Document Type: Article

References (28)

1. 2B) contractile receptor in the rat stomach fundus. J Med Chem 39:2773-2780.
2. Banes AKL and Watts SW (2002) Up-regulation of arterial serotonin-1b and -2B receptors in deoxycorticosterone acetate salt hypertension. Hypertension 39;394-398.
3. 2B receptor antagonist. J Ser Res 3:131-144.
4. 2B receptors of endothelium-dependent relaxation in rat jugular vein. Br J Pharmacol 114:400-404.
5. Glusa E and Roos A (1996) Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br J Pharmacol 119:3303-3307.
6. Foguet M, Hoyer D, Pardo LA, Parekh A, Kluxen FW, Kalkman O, Stuhmer W, and Lubbert H (1992) Cloning and functional expression of the rat stomach fundus serotonin receptor. EMBO (Eur Mol Biol Organ) J 11:3481-3487.
7. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane WJ, Saxena PR, and Humphrey PPA (1994) International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:158-203.
8. Hurley-Myers J, Mecca TE, and Webb RC (1985) Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle. J Cardiovasc Pharmacol 7 (Suppl 7):S44-S48.
9. Kavanaugh WM, Tilliams LT, Ives HE, and Coughlin SR (1988) Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol Endocrinol 2:599-605.
10. 2F) from rat stomach fundus. Mol Pharmacol 42:549-557.
11. 2B receptor. J Biol Chem 271:3141-3147.
12. Loric S, Maroteaux L, Kellermann O, and Launay JM (1995) Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation. Mol Pharmacol 47:458-466.
13. Martin GR (1994) Vascular receptor for 5-hydroxytryptamine: distribution, function and classification. Pharmacol Ther 62:283-324.
14. McGregor DD and Smirk FH (1970) Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats. Am J Physiol 219:687-690.
15. Pollock DM, Rekita A, Thakkar J, Allcock GH, and Pollock JS (1998) Different responses to chronic L-NAME treatment in Sprague-Dawley rats from different suppliers. FASEB J 12:A98.
16. Roson MI, Maquieira MK, and de la Riva IJ (1990) Contrasting effects of norepinephrine and 5-hydroxytryptamine on contractility of abdominal aorta of two kidney-two clip hypertensive rats. Effects of inhibitors of arachidonic acid metabolic enzymes. Clin Exp Hypertens A 12:285-306.
17. 2B serotonin receptor. FEBS Lett 342:85-90.
18. Simmons JC and Freeman RH (1995) L-Arginine analogues inhibit aldosterone secretion in rats. Am J Physiol 268:R1137-R1142.
19. Thompson LP and Webb RC (1987) Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Hypertension 9:277-281.
20. Vanhoutte PM (1991) Serotonin, hypertension and vascular disease. Neth J Med 38:35-42.
21. 2F receptor. Mol Pharmacol 43:419-426.
22. 2B receptor: evidence for species differences. J Pharmacol Exp Ther 276:720-727.
23. 2B receptor antagonist LY272015 inhibits 5-HT-induced contraction in the aorta of mineralocorticoid-salt hypertensive rats. J Ser Res 4:197-206.
24. Watts SW (1998) The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. J Hypertens 16:811-822.
25. 2B receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertension. J Pharmacol Exp Ther 277:1103-1113.
26. 2B receptor antagonist LY272015 is antihypertensive in DOCA-salt hypertensive rats. Am J Physiol Heart Circ 276:H944-H952.
27. 2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension 26:1056-1059.
28. 2B receptor in deoxycorticosterone acetate salt-treated rats blood pressure dependent? Gen Pharmacol 33:439-447.